| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.046 | 0.8 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.0078 | 0.8 |